General Information of DIG (ID: E0O1YN)
DIG Name
Piperazine
Synonyms    Click to Show/Hide the Synonyms of This DIG
piperazine; 110-85-0; Diethylenediamine; 1,4-Diazacyclohexane; Piperazin; Hexahydropyrazine; Piperazidine; Antiren; 1,4-Piperazine; Diethyleneimine; Eraverm; Pipersol; Dispermine; Lumbrical; Wurmirazin; Uvilon; Piperazine, anhydrous; Vermex; 1,4-Diethylenediamine; Worm-A-Ton; Asca-Trol No. 3; Pyrazine hexahydride; Hexahydro-1,4-diazine; Pyrazine, hexahydro-; Vermizine (TN); Piperazine (USP); NSC 474; UNII-1RTM4PAL0V; MFCD00005953; Piperazine [USP]; 1RTM4PAL0V; NSC474; CHEBI:28568; Eraverm (VAN); Piperazin [German]; NCGC00094762-03; Upixon; DSSTox_CID_1164; DSSTox_RID_75986; DSSTox_GSID_21164; Piperazine anhydrous; Piperazine, 99%, extra pure; Piperazin [Germany]; 1323940-30-2; Anhydrous piperazine; CAS-110-85-0; PZE; CCRIS 5950; 362049-61-4; HSDB 1093; EINECS 203-808-3; UN2579; PIPERAZINE-2,2,3,3,5,5,6,6-D8; BRN 0102555; piperizine; piperzine; piprazine; exahydropyrazine; Piperazine-; 7-piperazine; 4-diazacyclohexane; Piperazine, 99%; Tasnon (Salt/Mix); Exelmin (Salt/Mix); 525586-93-0; Vermidol (Salt/Mix); Vermizine (Salt/Mix); PubChem19047; Spectrum_001113; ACMC-1AWXD; PIPERAZINE-D10; Spectrum5_001817; WLN: T6M DMTJ; EC 203-808-3; Piperazine, p.a., 98%; CHEMBL1412; NCIOpen2_000984; NCIOpen2_000988; NCIOpen2_001024; NCIOpen2_001031; NCIOpen2_001033; NCIOpen2_001071; NCIOpen2_001073; NCIOpen2_001111; NCIOpen2_001151; NCIOpen2_001231; NCIOpen2_001262; NCIOpen2_001269; NCIOpen2_004830; NCIOpen2_004834; NCIOpen2_004862; NCIOpen2_004874; NCIOpen2_004904; NCIOpen2_004910; NCIOpen2_004914; NCIOpen2_004942; NCIOpen2_004952; NCIOpen2_004954; NCIOpen2_004982; NCIOpen2_004992; NCIOpen2_004994; NCIOpen2_005022; NCIOpen2_005032; NCIOpen2_005034; NCIOpen2_005062; NCIOpen2_005072; NCIOpen2_005102; NCIOpen2_005108; NCIOpen2_005145; NCIOpen2_005182; NCIOpen2_005185; NCIOpen2_005187; NCIOpen2_005200; NCIOpen2_005575; NCIOpen2_005980; NCIOpen2_009422; KBioSS_001593; 5-23-01-00030 (Beilstein Handbook Reference); ARONIS23910; BIDD:GT0273; DivK1c_000038; SPECTRUM1500490; Piperazine, analytical standard; DTXSID1021164; HMS500B20; KBio1_000038; KBio2_001593; KBio2_004161; KBio2_006729; NSC-474; MANGANESE(II)SILICOFLUORIDE; NINDS_000038; HMS1920H20; HMS2092A03; HMS3885L08; Pharmakon1600-01500490; 1$l^{2},4$l^{2}-diazinane; ACT02177; BCP24060; HY-B0912; Piperazine, ReagentPlus(R), 99%; STR00051; ZINC5850277; Tox21_113564; Tox21_202242; Tox21_300104; ANW-16201; BBL019924; NSC757283; s4574; STL169348; Piperazine [UN2579] [Corrosive]; Piperazine-[U-13C4] dihydrochloride; AKOS000269028; CCG-212753; CS-4381; DB00592; LF-0561; MCULE-5522245554; NSC-757283; Piperazine-[U-2,3,5,6-13C4]; UN 2579; IDI1_000038; NCGC00094762-01; NCGC00094762-02; NCGC00094762-04; NCGC00094762-05; NCGC00094762-08; NCGC00254077-01; NCGC00259791-01; Piperazine, anhydrous, >=99.0% (T); 8057-14-5; SBI-0051485.P003; FT-0673919; P0446; P0447; AZ0001-0086; 5726-EP2269610A2; 5726-EP2269977A2; 5726-EP2269993A1; 5726-EP2270002A1; 5726-EP2270006A1; 5726-EP2270010A1; 5726-EP2272509A1; 5726-EP2272517A1; 5726-EP2272813A2; 5726-EP2272841A1; 5726-EP2272935A1; 5726-EP2272972A1; 5726-EP2272973A1; 5726-EP2275395A2; 5726-EP2275401A1; 5726-EP2275404A1; 5726-EP2275411A2; 5726-EP2275412A1; 5726-EP2275420A1; 5726-EP2275421A1; 5726-EP2277848A1; 5726-EP2277858A1; 5726-EP2277867A2; 5726-EP2277872A1; 5726-EP2277876A1; 5726-EP2277877A1; 5726-EP2277880A1; 5726-EP2280003A2; 5726-EP2280005A1; 5726-EP2280006A1; 5726-EP2280008A2; 5726-EP2280009A1; 5726-EP2280010A2; 5726-EP2281563A1; 5726-EP2281810A1; 5726-EP2281813A1; 5726-EP2281815A1; 5726-EP2281818A1; 5726-EP2281819A1; 5726-EP2281821A1; 5726-EP2284149A1; 5726-EP2284157A1; 5726-EP2284159A1; 5726-EP2284160A1; 5726-EP2287163A1; 5726-EP2289510A1; 5726-EP2289868A1; 5726-EP2289883A1; 5726-EP2289884A1; 5726-EP2289887A2; 5726-EP2289888A2; 5726-EP2289894A2; 5726-EP2292586A2; 5726-EP2292593A2; 5726-EP2292606A1; 5726-EP2292610A1; 5726-EP2292611A1; 5726-EP2292614A1; 5726-EP2292619A1; 5726-EP2292624A1; 5726-EP2292630A1; 5726-EP2295399A2; 5726-EP2295402A2; 5726-EP2295407A1; 5726-EP2295409A1; 5726-EP2295426A1; 5726-EP2295427A1; 5726-EP2295429A1; 5726-EP2295432A1; 5726-EP2295433A2; 5726-EP2295437A1; 5726-EP2295438A1; 5726-EP2298731A1; 5726-EP2298734A2; 5726-EP2298736A1; 5726-EP2298738A1; 5726-EP2298743A1; 5726-EP2298755A1; 5726-EP2298763A1; 5726-EP2298766A1; 5726-EP2298767A1; 5726-EP2298772A1; 5726-EP2298775A1; 5726-EP2298778A1; 5726-EP2298783A1; 5726-EP2300432A1; 5726-EP2301928A1; 5726-EP2301936A1; 5726-EP2301937A1; 5726-EP2305219A1; 5726-EP2305250A1; 5726-EP2305646A1; 5726-EP2305648A1; 5726-EP2305651A1; 5726-EP2305657A2; 5726-EP2305659A1; 5726-EP2305672A1; 5726-EP2305677A1; 5726-EP2305678A1; 5726-EP2305679A1; 5726-EP2305682A1; 5726-EP2305684A1; 5726-EP2305687A1; 5726-EP2308510A1; 5726-EP2308562A2; 5726-EP2308812A2; 5726-EP2308838A1; 5726-EP2308839A1; 5726-EP2308840A1; 5726-EP2308848A1; 5726-EP2308854A1; 5726-EP2308857A1; 5726-EP2308867A2; 5726-EP2308870A2; 5726-EP2308872A1; 5726-EP2308873A1; 5726-EP2308875A1; 5726-EP2308879A1; 5726-EP2309584A1; 5726-EP2311464A1; 5726-EP2311808A1; 5726-EP2311814A1; 5726-EP2311818A1; 5726-EP2311824A1; 5726-EP2311828A1; 5726-EP2311829A1; 5726-EP2311831A1; 5726-EP2311842A2; 5726-EP2314295A1; 5726-EP2314574A1; 5726-EP2314575A1; 5726-EP2314584A1; 5726-EP2314586A1; 5726-EP2314587A1; 5726-EP2314588A1; 5726-EP2314590A1; 5726-EP2315760A1; 5726-EP2316457A1; 5726-EP2316458A1; 5726-EP2316470A2; 5726-EP2316825A1; 5726-EP2316826A1; 5726-EP2316827A1; 5726-EP2316828A1; 5726-EP2316829A1; 5726-EP2316831A1; 5726-EP2316832A1; 5726-EP2316833A1; 5726-EP2316836A1; 5726-EP2371811A2; 5726-EP2371831A1; 5726-EP2372804A1; 5726-EP2374895A1; 5726-EP2378585A1; B-6439; C07973; D00807; 10847-EP2284160A1; 10847-EP2284166A1; 10847-EP2292589A1; 10847-EP2295439A1; 10847-EP2301928A1; 10847-EP2305651A1; 10847-EP2308852A1; 10847-EP2308854A1; 10847-EP2316827A1; 10847-EP2316828A1; AB00052073_03; 164557-EP2281899A2; 164557-EP2287167A1; Piperazine, BioUltra, anhydrous, >=99.0% (T); Q409292; SR-05000001700; Q-201586; SR-05000001700-1; F0001-0226; Z1245537944; Piperazine, United States Pharmacopeia (USP) Reference Standard
DIG Function
Other agent
PubChem CID
4837
Formula
C4H10N2
Canonical SMILES
C1CNCCN1
InChI
1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2
InChIKey
GLUUGHFHXGJENI-UHFFFAOYSA-N
   Click to Show/Hide the Molecular Data (Structure/Property) of This DIG
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=4837"></iframe>
3D MOL 2D MOL
Physicochemical Properties Molecular Weight 86.14 Topological Polar Surface Area 24.1
XlogP -1.5 Complexity 26.5
Heavy Atom Count 6 Rotatable Bond Count 0
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 2
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG
       ICD Disease Classification 05 Endocrine/nutritional/metabolic disease Click to Show/Hide
Estropipate
API Info
Hypogonadism [ICD-11: 5A61]
[1]
References
1 FDA label for approved estropipate from the official website of the U.S. Food and Drug Administration.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.